Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK962040 Single Dose in Critically Ill Patients
NCT01039805Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2009
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of camicinal in gastroparesis, enteral feeding intolerance (EFI), sponsored by GSK. Started Dec 2009; status: completed.
02
Drugs
camicinal
03
Conditions
gastroparesisenteral feeding intolerance (EFI)
Beyond the preview
Go deeper on NCT01039805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01039805.